NCT00536549

Brief Summary

The purpose of this study is to determine whether the Guardian Continuous Glucose Monitoring System in the home setting is more useful than frequent self blood glucose monitoring with a view to modifying patient's diet and exercise habits or improvement self disease control efforts and at last glycemic control in patients with type 2 diabetes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
127

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
Completed

Started Feb 2007

Shorter than P25 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 27, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 28, 2007

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2007

Completed
Last Updated

May 20, 2008

Status Verified

May 1, 2008

Enrollment Period

8 months

First QC Date

September 27, 2007

Last Update Submit

May 19, 2008

Conditions

Keywords

Glucose monitoring systemlife style intervention

Outcome Measures

Primary Outcomes (1)

  • HbA1c, fasting blood glucose level, weight change, blood pressure in the morning, lipid profiles

    basline, 12weeks later

Secondary Outcomes (1)

  • three day diary meals and seven day physical activity diary

    basline, 12 weeks later

Study Arms (2)

A

EXPERIMENTAL

Guardina RT monitoring

Device: Guardian RT

B

ACTIVE COMPARATOR
Behavioral: Education about the self monitoring blood glucose

Interventions

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 diabetes
  • Group 1: HbA1c \< 8% with a stable insulin or oral hypoglycemic agents (OHA) regimen for the prior 2 months with no plans to switch modality of insulin or OHA administration during the next 3months.
  • Group 2: HbA1c \>= 8% and the fasting blood glucose must be \< 130 at the same time with a stable insulin or oral hypoglycemic agents (OHA) regimen for the prior 2 months with no plans to switch modality of insulin or OHA administration during the next 3months

You may not qualify if:

  • Use of corticosteroids or hormone therapy within the last 6 months
  • Presence of another chronic illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Endocrinology and Metabolism, Department of Internal Medicine,Korea University College of Medicine

Seoul, 152-703, South Korea

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Sei H Baik, MD

    Division of Endocrinology and Metabolism, Department of Internal Medicine,Korea University College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 27, 2007

First Posted

September 28, 2007

Study Start

February 1, 2007

Primary Completion

October 1, 2007

Study Completion

October 1, 2007

Last Updated

May 20, 2008

Record last verified: 2008-05

Locations